Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 056580/0658 | |
| Pages: | 7 |
| | Recorded: | 06/17/2021 | | |
| Attorney Dkt #: | UCSFP037C1US/P037WO |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
01/14/2020
|
Application #:
|
15508059
|
Filing Dt:
|
03/01/2017
|
|
Publication #:
|
|
Pub Dt:
|
12/21/2017
| | |
PCT #:
|
US2015049492
|
|
Title:
|
MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16691417
|
Filing Dt:
|
11/21/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/25/2020
| | | | |
|
Title:
|
MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS
|
|
|
Assignee
|
|
|
|
|
| 1111 FRANKLIN STREET, TWELFTH FLOOR |
| OAKLAND, CALIFORNIA 94607-5200 |
|
|
Correspondence name and address
|
| |
WEAVER AUSTIN VILLENEUVE & SAMPSON LLP
|
| |
P.O. BOX 70250
|
| |
OAKLAND, CA 94612-0250
|
Search Results as of:
05/02/2024 10:04 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
